Skip to content

InnoSIGN vs Ozette

InnoSIGN logo

InnoSIGN

Comprehensive Pathway Analysis

5 employees · est. 2022 · Eindhoven, The Netherlands

VS
Ozette logo

Ozette

Unlocking the power of the immune system through computationally-driven analytics

29 employees · est. 2021 · Seattle, United States

Ozette is the older company (2022 vs 2021); Ozette is the larger of the two.

Side-by-Side Comparison

InnoSIGN Ozette
Founded
2022 2021 older
Headquarters
Eindhoven, The Netherlands Seattle, United States
Employees
5 29 larger
Industry
Biotechnology, Life Sciences AI, Biotechnology, Life Sciences
Funding Stage
Series A Series A
Total Funding
$8.00M $32.00M
Funding Rounds
1 2
Services
Comprehensive Disease Analysis, Data Interpretation from Omics, Actionable Insights for Drug Development Adaptive Unmixing for Spectral Cytometry, AI-driven Computational Analysis, Data-driven Insights for Therapy Development, Collaborative Research and Clinical Development
Target Customers
Pharmaceutical Companies, Biotech Firms, Research Institutions, Healthcare Professionals Pharmaceutical Companies, Academic Researchers, Clinical Development Organizations, Biotech Professionals
Taxonomy
BiotechPrecision MedicinePathway AnalysisMRNA ProfilingSignaling PathwaysDisease Driver Events +9 ImmunologySingle-Cell AnalysisCytometryComputational AnalyticsSpectral UnmixingImmune Monitoring +9
Website
innosignbio.com ozette.com
InnoSIGN logo

About InnoSIGN

InnoSIGN, founded in 2022 and headquartered in The Netherlands, is a dynamic player in the Biotechnology and Life Sciences industries. The company’s tagline, "Comprehensive Pathway Analysis," encapsulates its mission to revolutionize disease understanding. InnoSIGN’s distinguishing feature is its b...

Ozette logo

About Ozette

Ozette, founded in 2021 and based in the United States, is pioneering advancements in the field of single-cell analysis with its proprietary, computationally-driven analytics platform. Specifically designed for cytometry data, Ozette's platform automates complex analytical workflows, from raw FCS fi...

Also comparing in this category

Comparing more than these two?

Get InnoSIGN, Ozette and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does InnoSIGN compare?

A PDF of InnoSIGN and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

InnoSIGN was founded in 2022, based in Eindhoven, The Netherlands, with 5 employees. InnoSIGN, founded in 2022 and headquartered in The Netherlands, is a dynamic player in the Biotechnology and Life Sciences industries. The company’s tagline, "Comprehensive Pathway Analysis," encapsul. Ozette was founded in 2021, based in Seattle, United States, with 29 employees. Ozette, founded in 2021 and based in the United States, is pioneering advancements in the field of single-cell analysis with its proprietary, computationally-driven analytics platform. Specifically de.
InnoSIGN has raised $8.00M and Ozette $32.00M. Latest stage: InnoSIGN Series A, Ozette Series A.
Both work in Biotechnology and Life Sciences.

Compare InnoSIGN with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at InnoSIGN on 21 May 2026, and Ozette on 2 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout